Addressing Gene Therapy
Financial Challenges

Published: March 16, 2022

2022 pbconference feature

– Identify challenges associated with financing and reimbursement of cell and gene therapies
– Describe emerging products to address risks associated with these treatment options
– Discuss implications and potential actionable next steps


Robert O’Brien, RPh, Vice President Specialty, Real Endpoints

View All Resources